UTMD
Closed
Utah Medical Products Inc
66.22
-0.11 (-0.17%)
Last Update: 06 Sep 2024 23:00:00
Yesterday: 66.33
Day's Range: 66. - 66.78
Send
sign up or login to leave a comment!
When Written:
93.6
Utah Medical Products Inc. (UTMD) is a publicly traded medical device company headquartered in Midvale, Utah. The company designs, develops, manufactures, and markets a range of medical devices used in critical care, women's health, and neonatal intensive care.
UTMD's product portfolio includes devices such as fetal monitoring systems, blood pressure monitoring systems, catheters, and surgical instruments. The company's products are used in hospitals, clinics, and other healthcare facilities across the world.
UTMD was founded in 1978 by Kevin L. Cornwell and is listed on the NASDAQ stock exchange under the ticker symbol UTMD. The company has a global presence with offices in the United States, Europe, and Asia. UTMD has a reputation for innovation and has received numerous awards for its products, including the Medical Design Excellence Award and the Frost & Sullivan Product Innovation Award.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
UTMD's product portfolio includes devices such as fetal monitoring systems, blood pressure monitoring systems, catheters, and surgical instruments. The company's products are used in hospitals, clinics, and other healthcare facilities across the world.
UTMD was founded in 1978 by Kevin L. Cornwell and is listed on the NASDAQ stock exchange under the ticker symbol UTMD. The company has a global presence with offices in the United States, Europe, and Asia. UTMD has a reputation for innovation and has received numerous awards for its products, including the Medical Design Excellence Award and the Frost & Sullivan Product Innovation Award.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!